User contributions
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 03:15, 29 September 2015 (diff | hist) . . (+52) . . Effect of Standardized Electronic Discharge Instructions on Post-Discharge Hospital Utilization
- 03:14, 29 September 2015 (diff | hist) . . (+35) . . Effect of Standardized Electronic Discharge Instructions on Post-Discharge Hospital Utilization
- 03:14, 29 September 2015 (diff | hist) . . (+83) . . N Category:Electronic discharge (Created page with "Electronic discharge helps in the overall discharge summary quality in an hospital.") (current)
- 01:48, 29 September 2015 (diff | hist) . . (+39) . . Leveraging of Open EMR Architecture for Clinical Trial Accrual
- 01:07, 29 September 2015 (diff | hist) . . (+29) . . Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction (→Comments)
- 01:01, 29 September 2015 (diff | hist) . . (+37) . . Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction
- 01:01, 29 September 2015 (diff | hist) . . (+115) . . N Category:Drug-gene interactions (Created page with "Drug-Gene Interactions happens when a patient's genetic CYP450 type affects that patient's ability to clear a drug.") (current)
- 00:47, 29 September 2015 (diff | hist) . . (+23) . . Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction
- 00:45, 29 September 2015 (diff | hist) . . (+224) . . Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction
- 00:40, 29 September 2015 (diff | hist) . . (+571) . . Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction
- 00:13, 29 September 2015 (diff | hist) . . (+96) . . CDS
- 00:08, 29 September 2015 (diff | hist) . . (+1,567) . . N Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction (Created page with "===Introduction=== Opioid prodrugs like Codeine and tramadol are metabolized in the liver by the cytochrome P450 2D6 enzyme (CYP2D6) and transferred in to active metabolites ...")
- 02:28, 24 September 2015 (diff | hist) . . (+1,354) . . Vendor Selection Criteria: Vendor assessment (→Vendor viability) (current)
- 02:01, 24 September 2015 (diff | hist) . . (0) . . Vendor Selection Criteria: Vendor assessment
- 01:56, 24 September 2015 (diff | hist) . . (+42) . . Vendor Selection Criteria: Vendor assessment (→Proposal rates)
- 01:24, 24 September 2015 (diff | hist) . . (+2) . . Vendor Selection Criteria: Vendor assessment (→Vendor Product Demonstration)
- 01:24, 24 September 2015 (diff | hist) . . (+902) . . Vendor Selection Criteria: Vendor assessment (→Evaluating Possible Software Vendors)
- 01:17, 24 September 2015 (diff | hist) . . (+579) . . Vendor Selection Criteria: Vendor assessment
- 03:08, 14 September 2015 (diff | hist) . . (+1,047) . . EMR Benefits: Healthcare quality (→Clinical decision support)
- 02:40, 14 September 2015 (diff | hist) . . (+569) . . EMR Benefits: Healthcare quality (→Patient Satisfaction)
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)